Публикации (по IF ) сотрудников подразделения (БД НИОХ СО РАН)

1. I.S. Merenkov, M.S. Myshenkov, Yu.M. Zhukov, Yo. Sato, T.S. Frolova, D.V. Danilov, I.A. Kasatkin, O.S. Medvedev, R.V. Pushkarev, O.I. Sinitsyna, M. Terauchi, I.A. Zvereva, M.L. Kosinova, K. Ostrikov
   Orientation-controlled, low-temperature plasma growth and applications of h-BN nanosheets
   Nano Research, 2019, V. 12, N 1, pp 91-99 doi:10.1007/s12274-018-2185-7, IF=8.515
    
2. M.V. Khvostov, E.D. Gladkova, S.A. Borisov, M.S. Fedotova, N.A. Zhukova, M.K. Marenina, Yu.V. Meshkova, N. Valutsa, O.A. Luzina, T.G. Tolstikova, N.F. Salakhutdinov
   9-N-n-alkyl Berberine Derivatives: Hypoglycemic Activity Evaluation
   Pharmaceutics 2023, 15(1), 44; doi:10.3390/pharmaceutics15010044, IF=6.525
    
3. M.V. Khvostov, E.D. Gladkova, S.A. Borisov, N.A. Zhukova, M.K. Marenina, Yu.V. Meshkova, O.A. Luzina, T.G. Tolstikova, N.F. Salakhutdinov
   Discovery of the First in Class 9-N-Berberine Derivative as Hypoglycemic Agent with Extra-Strong Action
   Pharmaceutics 2021, 13(12), 2138 doi:10.3390/pharmaceutics13122138, IF=6.321
    
4. M.V. Khvostov, E.D. Gladkova, S.A. Borisov, M.S. Fedotova, N.A. Zhukova, M.K. Marenina, Yu.V. Meshkova, O.A. Luzina, T.G. Tolstikova, N.F. Salakhutdinov
   Study of Hypoglycemic Activity of Novel 9-N-alkyltetrahydroberberine Derivatives
   Int. J. Mol. Sci. 2022, 23(22), 14186 doi:10.3390/ijms232214186, IF=6.208
    
5. V.A. Demina, S.V. Krasheninnikov, A.I. Buzin, R.A. Kamyshinsky, N.V. Sadovskaya, E.N.Goncharov, N.A. Zhukova, M.V. Khvostov, A.V. Pavlova, T.G. Tolstikova, N.G. Sedush, S.N. Chvalun
   Biodegradable poly(l-lactide)/calcium phosphate composites with improved properties for orthopedics: Effect of filler and polymer crystallinity
   Materials Science and Engineering: C, 2020, V. 112, 110813 doi:10.1016/j.msec.2020.110813, IF=5.88
    
6. S.V. Valiulin, A.A. Onischuk, A.M. Baklanov, S.N. Dubtsov, S.V. An'kov, N.N. Shkil, E.V. Nefedova, M.E. Plokhotnichenko, T.G. Tolstikova, A.M. Dolgov, G.G. Dultseva
   Aerosol Inhalation Delivery of Cefazolin in Mice: Pharmacokinetic Measurements and Antibacterial Effect
   International Journal of Pharmaceutics, V. 607, 25 September 2021, 121013 doi:10.1016/j.ijpharm.2021.121013, IF=5.875
    
7. D.F. Avgustinovich, M.K. Marenina, S.Ya. Zhanaeva, M.V. Tenditnik, A.V. Katokhin, K.S. Pavlov, A.Yu. Sivkov, G.B. Vishnivetskaya, M.N. Lvova, T.G. Tolstikova, V.A. Mordvinov
   Combined effects of social stress and liver fluke infection in a mouse model
   Brain, Behavior, and Immunity, 2016, V. 53, Pp 262-272 doi:10.1016/j.bbi.2016.01.012, IF=5.874
    
8. A.S. Filimonov, O.I. Yarovaya, A.V. Zaykovskaya, N.B. Rudometova, D.N. Shcherbakov, V.Yu. Chirkova, D.S. Baev, S.S. Borisevich, O.A. Luzina, O.V. Pyankov, R.A. Maksyutov, N.F. Salakhutdinov
   (+)-Usnic Acid and Its Derivatives as Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses
   Viruses 2022, 14(10), 2154 doi:10.3390/v14102154, IF=5.817
    
9. E. Pashkina, V. Evseenko, N. Dumchenko, M. Zelikman, A. Aktanova, M. Bykova, M. Khvostov, A. Dushkin, V. Kozlov
   Preparation and Characterization of a Glycyrrhizic Acid-Based Drug Delivery System for Allergen-Specific Immunotherapy
   Nanomaterials 2022, 12(1), 148 doi:10.3390/nano12010148, IF=5.719
    
10. A. Predtetchinski, E. Predtechenskaya, I. Sorokina, A. Guzev, S. Aydagulova
    Morphologic changes and protective role of prolactin in experimental multiple sclerosis animal model
    MULTIPLE SCLEROSIS JOURNAL, 2019, V.25, S2, Pp 435-435 (P845) (35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS Местоположение: Stockholm, SWEDEN публ.: SEP 11-13, 2019 Конференция: 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual MULTIPLE SCLEROSIS JOURNAL Том: 25 Специальный выпуск: SI Приложение: 2 Стр.: 435-435 Аннотация к встрече: P845 Conference of Rehabilitation in MS Местоположение: Stockholm, SWEDEN публ.: SEP 11-13, 2019, IF=5.649
     
11. A.S. Sokolova, O.I. Yarovaya, A.V. Zybkina, E.D. Mordvinova, N.S. Shcherbakova, A.V. Zaykovskaya, D.S. Baev, T.G. Tolstikova, D.N. Shcherbakov, O.V. Pyankov, R.A. Maksyutov, N.F. Salakhutdinov
    Monoterpenoid-based inhibitors of filoviruses targeting the glycoprotein-mediated entry process
    European Journal of Medicinal Chemistry, 2020, V. 207, 112726 doi:10.1016/j.ejmech.2020.112726, IF=5.572
     
12. M. V.Khvostov,N. V.Bulina,N. A.Zhukova,E. G.Morenkov,D. K.Rybin,S. V.Makarova,S. V.Leonov,V.S.Gorodov,V.Yu.Ulianitsky,T.G.Tolstikova
    A study on biological properties of titanium implants coated with multisubstituted hydroxyapatite
    Ceramics International, 48(23), с. 34780-34792 doi:10.1016/j.ceramint.2022.08.067, IF=5.532
     
13. S.V. Valiulin, A.A. Onischuk, A.M. Baklanov, S.N. Dubtsov, G.G. Dultseva, S.V. An'kov, T.G. Tolstikova, S.N. Belogorodtsev, Ya.Sh. Schwartz
    Studies of the Specific Activity of Aerosolized Isoniazid against Tuberculosis in a Mouse Model
    Antibiotics 2022, 11(11), 1527 doi:10.3390/antibiotics11111527, IF=5.222
     
14. S. V. Valiulin, A. A. Onischuk, A. M. Baklanov, S. V. An’kov, S. N. Dubtsov, A A. Alekseev, N. N. Shkil, E V. Nefedova, M. E. Plokhotnichenko, T. G. Tolstikova, A M. Dolgov, G G. Dultseva
    Aerosol Inhalation Delivery of Ceftriaxone in Mice: Generation Procedure, Pharmacokinetics, and Therapeutic Outcome
    Antibiotics 2022, 11(10), 1305; doi:10.3390/antibiotics11101305, IF=5.222
     
15. E.O. Shestakova, S.G. Il'yasov, I.A. Shchurova, V.S. Glukhacheva, D.S. Il'yasov, E.E. Zhukov, A.O. Bryzgalov, T.G. Tolstikova, Yu.V. Gatilov
    Investigation of 1,4-Substituted 1,2,3-Triazole Derivatives as Antiarrhythmics: Synthesis, Structure, and Properties
    Pharmaceuticals 2022, 15(12), 1443 doi:10.3390/ph15121443, IF=5.215
     
16. O.V. Ardashov, A.V. Pavlova, I.V. Il'ina, E.A. Morozova, D.V. Korchagina, E.V. Karpova, K.P. Volcho, T.G. Tolstikova, N.F. Salakhutdinov
    Highly potent activity of (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in animal models of Parkinson's disease
    J. Med. Chem., 2011, V. 54, N 11, 3866-74. doi:10.1021/jm2001579, IF=5.206
     
17. D. Pon'kina, S. Kuranov, M. Khvostov, N. Zhukova, Yu. Meshkova, M. Marenina, O. Luzina, T. Tolstikova, N. Salakhutdinov
    Hepatoprotective Effect of a New FFAR1 Agonist-N-Alkylated Isobornylamine
    Molecules 2023, 28(1), 396; doi:10.3390/molecules28010396, IF=4.927
     
18. D.S. Baev, M.E. Blokhin, V.Yu. Chirkova, S.V. Belenkaya, O.A. Luzina, O.I. Yarovaya, N.F. Salakhutdinov, D.N. Shcherbakov
    Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
    Molecules 2023, 28(1), 303 doi:10.3390/molecules28010303, IF=4.927
     
19. D.V. Reshetnikov, I.D. Ivanov, D.S. Baev, T.V. Rybalova, E.S. Mozhaitsev, S.S. Patrushev, V.A. Vavilin, T.G. Tolstikova, E.E. Shults
    Design, Synthesis and Assay of Novel Methylxanthine–Alkynylmethylamine Derivatives as Acetylcholinesterase Inhibitors
    Molecules 2022, 27(24), 8787 doi:10.3390/molecules27248787, IF=4.927
     
20. S. Kuranov, M. Marenina, D. Ivankin, M. Blokhin, S. Borisov, T. Khomenko, O. Luzina, M. Khvostov, K. Volcho, T. Tolstikova, N. Salakhutdinov
    The Study of Hypoglycemic Activity of 7-Terpenylcoumarins
    Molecules 2022, 27(24), 8663 doi:10.3390/molecules27248663, IF=4.927